PTN earnings date and last-quarter result: next report 2026-09-02, last quarter miss, P/E -1.75. Updated 2026-07-23.
Palatin Technologies (PTN) Research Hub
Palatin Technologies (PTN) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 4.82 USD (-5.68%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1.75, market cap 0.01B. This hub links to the full technical, earnings and options research available for PTN.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 4.82 USD (-5.68%) |
| 52-week range | 4.58 USD – 14.01 USD |
| Trend regime | Range |
| 14-day RSI | 2.9 (Oversold) |
| Trailing P/E | -1.75 |
| Market cap | 0.01B |
| Dividend yield | 0.00% |
| Next earnings | 2026-09-02 |
Available research for PTN
Covered Call on PTN: how it works, illustrative setup around the real 4.82 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on PTN: how it works, illustrative setup around the real 4.82 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on PTN: how it works, illustrative setup around the real 4.82 USD price, max profit/loss, breakeven and when to use it. Educational.
PTN technical analysis: range, last 4.82 USD, RSI 2.9, 52w range 4.58 USD–14.01 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is PTN in?
Palatin Technologies (PTN) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is PTN in an uptrend or downtrend?
As of 2026-10-26, PTN is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is PTN's trailing P/E ratio?
PTN's trailing P/E is -1.75, with a market cap of 0.01B. See the earnings research page for full valuation detail.
When does PTN next report earnings?
PTN is next scheduled to report earnings on 2026-09-02.